List of insiders holdings for ArriVent BioPharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | HILLHOUSE INVESTMENT MANAGEMENT LTD. HHLR ADVISORS LTD. 10% Owner | 2024-11-14 16:33:47 | 4,484,672 0 | 4,484,672 | Form 13G |
| 2 | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner | 2024-02-05 16:42:18 | 3,027,328 0 | 3,027,328 | Form 13D |
| 3 | HEALY JAMES Director | 2024-01-31 16:10:47 | 0 1,696,752 | 1,696,752 | Form 4 |
| 4 | GORDON CARL L Director 10% Owner | 2024-01-31 16:11:43 | 0 1,513,664 | 1,513,664 | Form 4 |
| 5 | Yao Zhengbin President and CEO | 2025-02-14 16:27:36 | 380,000 0 | 380,000 | Form 4 |
| 6 | Kung Winston Chief Financial Officer | 2025-02-14 16:24:52 | 120,000 0 | 120,000 | Form 4 |
| 7 | LaChapelle Robin Chief Operating Officer | 2025-02-14 16:25:46 | 120,000 0 | 120,000 | Form 4 |
| 8 | Lutzker Stuart President of R&D | 2025-02-14 16:26:40 | 120,000 0 | 120,000 | Form 4 |
| 9 | Kastenmayer James Paul General Counsel | 2025-02-14 16:23:58 | 102,000 0 | 102,000 | Form 4 |
| 10 | Hohneker John Director | 2024-05-20 17:30:56 | 29,550 0 | 29,550 | Form 4 |
| 11 | Peterson Kristine Director | 2024-04-23 16:06:26 | 28,587 0 | 28,587 | Form 4 |
| 12 | Parsey Merdad Director | 2025-04-29 16:51:43 | 28,346 0 | 28,346 | Form 4 |
| 13 | Jallal Bahija Director | 2024-01-29 16:15:57 | 17,884 0 | 17,884 | Form 4 |
| 14 | Nolet Chris Director | 2024-01-29 16:16:13 | 17,884 0 | 17,884 | Form 4 |